Radiology, Radiation Oncology · Corpus Christi, TX
NPI
1164531273
Since 2006
Specialty
Radiology, Radiation Oncology
Code 2085R0001X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
1205 S 19th St, Suite A
Corpus Christi, TX, 78405
Phone (361) 561-4193
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.4M
13,145 services
Medicare patients, 2024
244
Average age 76
Drug cost, 2024
$6.5M
608 prescriptions
Company payments, 2025
$30K
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jim Hsiang was code J0897 (injection, denosumab, 1 mg), 6,240 times for 40 patients. In total Jim Hsiang billed 13,145 services in 36 codes, and Medicare paid $1.4M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-01-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 6,240 | 40 | $20.19 | $126K |
| 77014 Conventional Radiation Treatment | Office | 1,613 | 49 | $90.99 | $147K |
| G6015 Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | Office | 1,610 | 49 | $266.81 | $430K |
| 77300 Radiation Treatment Planning | Office | 550 | 43 | $50.94 | $28K |
| 77336 Radiation Treatment Planning | Office | 316 | 51 | $68.59 | $22K |
| 77427 Conventional Radiation Treatment | Office | 311 | 50 | $153.39 | $48K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 306 | 173 | $13.38 | $4,094 |
| 99214 Office E&M - Established | Office | 244 | 152 | $90.71 | $22K |
| 99215 Office E&M - Established | Office | 199 | 97 | $138.73 | $28K |
| 96401 Chemotherapy Administration | Office | 95 | 43 | $48.69 | $4,625 |
| 77338 Radiation Treatment Planning | Office | 76 | 39 | $372.66 | $28K |
| 99205 Office E&M - New | Office | 57 | 57 | $166.94 | $9,516 |
| 36415 Venipuncture Blood Collection | Office | 42 | 42 | $8.48 | $356 |
| 77263 Radiation Treatment Planning | Office | 40 | 39 | $133.26 | $5,331 |
| 77334 Radiation Treatment Planning | Office | 40 | 38 | $100.32 | $4,013 |
By year: 2022 $1.3M for 14,770 services; 2023 $1.9M for 17,312 services; 2024 $1.4M for 13,145 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 42 | 42 | $8.48 | $356 |
| 82272 Immunoassay | 11 | 11 | $4.15 | $45.65 |
Medicare prescription drug claims, 2024
In 2024, the drug Jim Hsiang prescribed most often to Medicare patients was Xtandi (Enzalutamide), with 352 prescriptions and refills. In total Jim Hsiang wrote 608 Medicare prescriptions that cost $6.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Xtandi Enzalutamide | 352 | 352 | 45 | $4.9M |
| Erleada Apalutamide | 90 | 90 | 11 | $1.3M |
| Tamsulosin Hcl Generic | 80 | 122 | 41 | $393 |
| Xgeva Denosumab | 28 | 44 | Under 11 | $95K |
| Prolia Denosumab | 22 | 120 | 15 | $38K |
| Abiraterone Acetate Generic | 15 | 15 | Under 11 | $50K |
| Prednisone Generic | 13 | 13 | Under 11 | $19.39 |
Brand drugs: 497 claims; generic drugs: 111 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jim Hsiang $30K ($30K in general payments such as food, travel and fees) from 10 companies. The largest payer was Dendreon Pharmaceuticals LLC with $16K.
| Company | Payments | Amount |
|---|---|---|
| Dendreon Pharmaceuticals LLC | 17 | $16K |
| Astellas Pharma US Inc 4503.T | 13 | $14K |
| Janssen Biotech, Inc. JNJ | 5 | $130 |
| Pfizer Inc. PFE | 7 | $120 |
| Seagen Inc. PFE | 1 | $75.99 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 3 | $69.14 |
| Caris MPI, Inc. | 3 | $68.94 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $64.16 |
| Boston Scientific Corporation BSX | 1 | $28.51 |
| Teleflex LLC TFX | 1 | $22.62 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.